Background While partial nephrectomy (PN) is the recommended treatment for many small
renal masses, anatomically complex tumors necessitate a clear understanding of the …

Simple Summary Renal cell carcinoma (RCC) in metastatic form is a lethal pathology difficult
to treat; therefore, the research of new therapeutic options for the treatment of metastatic …

Background Nephron-sparing surgery is the preferred surgical management of cT1 renal
masses, but observational and randomized data conflict regarding a survival benefit …

Objective. Tumour characteristics, preoperative work-up and surgical treatment in patients
diagnosed with renal cell carcinoma (RCC) between 2005 and 2010, and changes over time …

Purpose: To assess epidemiologic characteristics, clinical and pathologic patterns of
presentation, and treatment strategies in a contemporary population with renal masses …

Purpose: We evaluated contemporary practice patterns in the management of small renal
masses. Materials and Methods: We identified 52,804 patients in the NCDB (National …

Results: A total of 78,891 patients met inclusion criteria. Of 70,212 patients diagnosed since
1983, 10.4% had missing data. Significant attenuation in cancer-specific mortality was noted …

Introduction Cryoablation (CA) has been broadly used mostly in the treatment of small renal
masses (SRMs). The present review aims to define the current role of CA in the treatment of …

Objective Active surveillance (AS) represents a fundamental shift in managing select cancer
patients that initiates treatment only upon disease progression to avoid overtreatment. Given …

Context Cabozantinib combined with immune checkpoint inhibitors (ICIs) has brought a new
therapeutic effect for the medical treatment of renal cell carcinoma (RCC). Objectives We …